CYTK

CYTK Stockholders Equity

-$173.49MQuarterly · USD

Period ending:

CYTK FY Shareholders EquityUSD
CYTK FY Shareholders Equity2000-12-31: -$21.82M2001-12-31: -$37.35M2002-12-31: -$60.59M2003-12-31: -$92.03M2004-12-31: $107.56M2005-12-31: $73.56M2006-12-31: $106.31M2007-12-31: $99.92M2008-12-31: $49.77M2009-12-31: $101.43M2010-12-31: $70.52M2011-12-31: $48.18M2012-12-31: $71.44M2013-12-31: $54.44M2014-12-31: $92.06M2015-12-31: $68.59M2016-12-31: $94.36M2017-12-31: $109.84M2018-12-31: $25.93M2019-12-31: -$10.94M2020-12-31: $113.38M2021-12-31: $243.86M2022-12-31: -$107.90M2023-12-31: -$386.32M2024-12-31: -$135.37M2025-12-31: -$659.63M$243.86M-$659.63M
2000-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CYTK stockholders equity history

Net worth of the company (assets minus liabilities). The available annual fiscal periods series contains 26 observations from Dec 31, 2000 to Dec 31, 2025.

Cytokinetics Inc Stockholders Equity — Annual fiscal periods (USD)
Period endingStockholders Equity (USD)
-659,625,000
-135,372,000
-386,323,000
-107,900,000
243,863,000
113,383,000
-10,937,000
25,934,000
109,842,000
94,361,000
68,590,000
92,064,000
54,442,000
71,440,000
48,178,000
70,516,000
101,429,000
49,766,000
99,916,000
106,313,000
73,561,000
107,556,000
-92,031,000
-60,588,000
-37,352,000
-21,818,000

Compare stockholders equity

All CYTK financial metrics · CYTK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.